Drug Farm Announces anti-HBV immunomodulator, DF-006 is Accepted as a Late-Breaking Presentation at the 2024 European Association for the Study of the Liver Conference
Business Wire
GUILFORD, Conn.--(BUSINESS WIRE)--Drug Farm, a private biotechnology company utilizing genetics and artificial intelligence..